Valye reports for unlimited access

LAMY is a Wyoming-incorporated startup focused on educational gaming and eLearning, delivering financial literacy and resource management education to children through its twoplus1® video game platform. The company has recently expanded into the cancer therapy sector through the strategic acquisition of Exousia AI, Inc., integrating novel cancer diagnostic and therapeutic technologies. LAMY pursues growth via technology innovation, strategic partnerships, and licensing agreements, targeting niche markets with relatively low startup costs and leveraging user-generated content and creator economy tools.

GAP INC is an omni-channel retailer offering apparel, accessories, and personal care products under the Old Navy, Gap, Banana Republic, and Athleta brands. The company operates thousands of stores globally and leverages franchise and licensing agreements to expand its footprint internationally. It integrates digital and physical retail channels to provide a seamless shopping experience, including services like buy online pick-up in store and ship-from-store. GAP INC designs and develops most of its products internally and sources manufacturing globally. The company maintains private label and co-branded credit card programs to enhance customer engagement. Financially, GAP INC reported $15.37 billion in revenue and $816 million in net income for fiscal 2025, with a solid liquidity profile and ongoing share repurchase and dividend programs.

Xerox Holdings Corp operates as a workplace technology company delivering services-led, software-enabled solutions globally. It serves a broad customer base across multiple industries and geographies. The business is organized into two reportable segments: Print and Other, which includes Workplace Solutions, Production Solutions, Xerox Services, and Xerox Financial Services; and IT Solutions, which offers integrated IT infrastructure and managed services. The company’s 2025 Reinvention strategy aims to strengthen core operations, improve financial flexibility, and expand into higher-growth verticals beyond print. Key recent developments include the acquisition of Lexmark and integration of ITsavvy, enhancing product offerings and market reach. Xerox’s revenue streams are largely post-sale based, providing stability through managed print services, supplies, and financing. The company maintains a global footprint with approximately 43% of revenue generated outside the U.S.

Frequency Electronics Inc. designs, develops, manufactures, and markets precision time and frequency control products primarily for U.S. Government and commercial satellite markets, as well as defense applications. The company operates two reportable segments: FEI-NY, focused on satellite payloads and ground-based communication systems, and FEI-Zyfer, which provides GPS-based positioning, navigation, and timing products. Its products are used in secure communications, intelligence collection, and precision targeting systems. The company holds a DCAA audited accounting system enabling direct government contracts and maintains a backlog of approximately $70 million as of April 2025. It faces competition from larger firms but competes on product performance and reliability. The company invests in R&D to improve its technologies and product manufacturability.

MGT CAPITAL INVESTMENTS, INC. is a Delaware corporation with a history in cryptocurrency mining and hosting, primarily focused on Bitcoin. During 2025, the company ceased active mining operations and sold its main facility, transitioning away from direct mining activities. It retains 35 Antminer S19 Pro mining units in storage and is engaged in a strategic review to identify new business opportunities leveraging its technology and digital asset expertise. The company currently has no active revenue-generating operations and is dependent on raising additional capital to fund its transition and working capital needs. It faces significant operational, financial, and market risks including Bitcoin price volatility, regulatory uncertainties, and liquidity challenges.

M3-Brigade Acquisition VI Corp. is a special purpose acquisition company (SPAC) incorporated in June 2025 in the Cayman Islands. It was formed by executives from M3 Partners, LP and Brigade Capital Management, LP, both established financial firms with extensive experience in advisory and credit-focused investment strategies. The company completed its initial public offering in August 2025, raising $345 million, which is held in a trust account invested in U.S. government securities. The company has not yet engaged in any business operations or generated revenue. Its primary objective is to identify and complete an initial business combination with one or more target companies, potentially in disruptive growth sectors such as cryptocurrency and blockchain, focusing on North American and European markets. The management team has a track record of leading multiple prior SPACs and business combinations. The company’s financial position as of December 31, 2025, shows strong liquidity with a current ratio of 3.69 and net income driven by investment income from the trust account. Public shareholders have rights to redeem their shares upon completion of the business combination. The company’s financial statements have been audited with an unqualified opinion.

Bank7 Corp. operates as the holding company for Bank7, a financial institution based in Oklahoma City, Oklahoma. The company is publicly traded on NASDAQ under the ticker BSVN. It provides banking services and has disclosed financial results for fiscal year 2025, including net income and earnings per share. Governance includes oversight of cybersecurity risks by senior management and the Board of Directors. The company has engaged in stock buyback programs and dividend increases, with analyst coverage noting an Outperform rating.

ProCap Acquisition Corp operates as a Special Purpose Acquisition Company (SPAC) with the objective of effecting a Business Combination with one or more businesses, primarily targeting the financial services sector. Incorporated in January 2025, the company completed its IPO in May 2025, raising gross proceeds of $250 million plus $4.3 million from a private placement to its Sponsor. The company has not generated operating revenues and does not expect to do so until after completing its initial Business Combination. Management is led by CEO Anthony Pompliano, leveraging his legacy finance experience and significant social media presence to identify and support potential targets. The company must complete its Business Combination by May 2027, with the option to extend. It maintains strong liquidity, with current assets significantly exceeding current liabilities as of the end of 2025.

Telesat Corp is a Canadian satellite communications company headquartered in Ottawa, Ontario. It focuses on delivering next-generation satellite and marine technologies, including military satellite communications solutions through strategic partnerships with government and industry players. The company reported annual revenue of CAD 417.956 million and a net loss of CAD 530.217 million for the fiscal year ended December 31, 2025. Liquidity ratios indicate current liabilities significantly exceed current assets, reflecting financial pressures. Telesat has been active in signing strategic cooperation agreements and has recently appointed a new CFO, indicating ongoing management and operational developments.

Abeona Therapeutics Inc. is a Delaware-based commercial-stage biopharmaceutical company specializing in cell and gene therapies targeting rare and life-threatening diseases. Its lead product, ZEVASKYN, received FDA approval in April 2025 as the first autologous cell-based gene therapy for treating wounds in patients with recessive dystrophic epidermolysis bullosa (RDEB), a severe genetic skin disorder. ZEVASKYN is manufactured in-house at Abeona's cGMP facility in Cleveland, Ohio, and administered through a network of qualified treatment centers across the U.S. The company has initiated commercial sales of ZEVASKYN and secured broad insurance coverage, including a permanent CMS J-code to facilitate reimbursement. Abeona's development pipeline includes AAV-based gene therapies for ophthalmic diseases using proprietary AIM™ capsid technology, with several candidates in preclinical stages. The company maintains a robust manufacturing platform and collaborates with academic and industry partners to advance its therapeutic programs.

Bicycle Therapeutics plc develops a novel class of medicines called Bicycle® molecules, which are fully synthetic short peptides constrained to form two loops, enabling high affinity and selective target binding. These molecules combine the pharmacology of biologics with the manufacturing and pharmacokinetic properties of small molecules, offering a unique therapeutic modality. The company’s proprietary phage display screening platform encodes quintillions of potential Bicycle molecules, facilitating efficient identification and optimization of candidates. Internal programs focus on oncology indications with high unmet medical need, including clinical-stage candidates such as nuzefatide pevedotin and zelenectide pevedotin. The company also collaborates with biopharmaceutical partners in other therapeutic areas. Bicycle Therapeutics operates primarily in the United States and the United Kingdom and relies on third-party manufacturers and contract research organizations for clinical development and manufacturing. The company has implemented cost reduction initiatives and strategic reprioritization to focus on next-generation therapeutics and reduce operating expenses.

Lifeway Foods, Inc. operates in the cultured dairy product segment, with recent product innovation including the launch of Probiotic Kefir Butter™, a premium European-style cultured butter. The company communicates regularly through earnings releases and press announcements. Financial disclosures indicate a stable liquidity position and positive net income for the fiscal year ended December 31, 2025. The company has amended its credit facilities to accommodate capital expenditures related to plant optimization and capacity expansion. Insider share sales have been reported during 2025, reflecting some insider liquidity activity. The company is covered by analysts, with Benchmark initiating coverage with a buy recommendation in November 2025.

FREIT is an equity real estate investment trust that owns and manages a diversified portfolio of income-producing properties, including residential apartment communities and commercial retail centers, primarily located in northern New Jersey and New York. The company operates two main segments: residential and commercial properties, each managed with distinct strategies. FREIT's business model centers on generating rental income from long-term leases and strategically managing its portfolio through acquisitions, developments, and selective property sales to enhance returns. The company maintains a significant mortgage debt portfolio with fixed interest rates and a revolving credit facility to support operations and growth. Recent financial disclosures indicate stable revenue and net income generation, with active management of loan maturities and refinancing efforts.

Comstock Holding Companies, Inc. specializes in managing, developing, and operating mixed-use and transit-oriented real estate assets primarily in the Washington, D.C. metropolitan area. Since 1985, it has acquired, developed, and managed millions of square feet of residential, commercial, and mixed-use properties. The company’s business model centers on generating recurring, fee-based revenue through long-term asset management and property management agreements. Its managed portfolio includes a diverse set of assets such as Trophy and Class A office towers, luxury residential buildings, branded hotels, retail spaces, and parking facilities. The Anchor Portfolio, comprising Reston Station and Loudoun Station, represents some of the largest and most prominent mixed-use developments in the region. Comstock operates through wholly owned subsidiaries for commercial, residential, and parking management services, maintaining market-rate fees. The company’s asset-light and debt-free approach mitigates typical real estate risks and provides flexibility for growth and strategic investments. Its client base includes institutional investors, family offices, financial institutions, and government entities. The company reported $62.9 million in revenue and $17.1 million in net income for 2025, with strong liquidity and a growing managed portfolio.

Expion360 Inc. designs and manufactures lithium iron phosphate (LiFePO4) batteries and related accessories, focusing on applications in recreational vehicles, marine, and industrial sectors. The company’s product portfolio includes the e360 line, which targets customers transitioning from traditional lead-acid batteries to lithium-based solutions. Expion360 serves approximately 300 customers across the U.S., including dealers, wholesalers, private-label customers, and OEMs, with significant sales concentration among a few key customers. The company sources battery cells and components from multiple global suppliers to mitigate supply chain risks. It holds intellectual property protections through patents and trademarks and maintains strategic partnerships to expand into new markets such as industrial energy storage. Expion360 has experienced recent leadership transitions and continues to invest in product development and sales channels. The company reported $9.65 million in revenue and a net loss of $6.2 million for the fiscal year ended 2025, with strong liquidity metrics but ongoing operating losses.

Lake Shore Bancorp, Inc. operates as the parent holding company of Lake Shore Bank, a community bank with ten branches in Western New York, primarily serving Erie and Chautauqua Counties. The bank’s principal business is attracting retail deposits and investing those funds primarily in commercial real estate loans, residential mortgage loans, home equity lines of credit, commercial business loans, consumer loans, and investment securities. Revenues are principally derived from interest earned on loans and investments. The bank retains most loans it originates but may sell residential mortgage loans with servicing rights retained to manage risk. The company completed its mutual-to-stock conversion in July 2025, raising approximately $49.5 million in gross proceeds from its initial stock offering. The bank operates under regulation by the Federal Reserve Board, New York Department of Financial Services, and FDIC. The local economy in Western New York has experienced growth in healthcare, education, and downtown revitalization, which influences lending opportunities. The company faces intense competition from larger regional banks, credit unions, online banks, and non-depository financial service providers. Lending policies are approved annually by the Board of Directors with defined credit approval authorities. The company employs approximately 98 people and supports employee development and ownership through an ESOP program.

IceCure Medical Ltd. develops and commercializes cryoablation medical devices that use liquid nitrogen to freeze and destroy tumors and other tissues. Its flagship product, the ProSense system, is FDA authorized for treating biologically low-risk breast cancer in women aged 70 and above receiving adjuvant endocrine therapy. The company also markets the XSense system with CryoProbes and is developing the MSense system for larger and multiple tumors. IceCure's products have regulatory approvals in multiple countries, and it sells systems and disposables primarily to hospitals, clinics, and distributors. The company operates a razor/razor blade sales model, where system placements drive disposables sales. Manufacturing is largely outsourced with final assembly in Israel. IceCure has incurred significant operating losses since inception and reported a net loss of $15.057 million in 2025 on revenues of $3.379 million. It maintains liquidity with $8.9 million in cash and equivalents as of year-end 2025 but faces ongoing capital requirements to fund operations and product development [S1].

Marwynn Holdings, Inc. is a holding company incorporated in Nevada in 2024, conducting operations through subsidiaries. Its main operating subsidiary, FuAn Enterprise, Inc., specializes in sourcing and distributing premium Asian foods and non-alcoholic beverages to U.S. markets, including mainstream grocery stores and wholesale clubs. The company also provides supply chain consulting and market expansion services. In late 2025, Marwynn exited the indoor home improvement supply chain business by selling Grand Forest Cabinetry Inc. and expanded into the e-waste reverse supply chain sector through its subsidiary EcoLoopX Corporation, which focuses on coordination and logistics without physical processing of e-waste. The company derives revenues from food and beverage sales, consulting services, and recyclable e-waste materials sales. It faces challenges from U.S. trade policy changes, including tariffs and import restrictions, particularly affecting imports from China, leading to alternative sourcing strategies and product adjustments. Marwynn is actively diversifying its market channels and working with major retailers. The company reported a net loss for the recent quarter and maintains liquidity through various financing sources but has noted substantial doubt about its ability to continue as a going concern without additional financing.

Guru App Factory Corp is a development-stage company focused on mobile application development and software development consulting services. Incorporated in Nevada in March 2023, the company develops, publishes, and sells mobile apps on iOS and Google Play platforms. It generates revenue from app development for third parties, branded advertisements, and consumer transactions including in-app purchases. The company also offers consulting services in software development, data encryption, blockchain operation and development, and software development with a focus on encryption and data protection. Revenue is recognized at the point in time when services are performed and accepted by customers. The company’s financials as of January 31, 2026 show total assets of $9,000, total liabilities of $41,481, and a stockholders' deficit of $32,481. It reported a net loss of $31,178 for the six-month period ended January 31, 2026, with cash and cash equivalents of $1,000. The company has not established a sustainable revenue stream sufficient to cover operating costs and relies on financial support from its major shareholder and related party advances. It has no bank financing arrangements and plans to fund operations through equity or debt issuances. The company’s financial statements include a going concern note highlighting substantial doubt about its ability to continue as a going concern for the next year.

Neuronetics, Inc. develops and markets the NeuroStar Advanced Therapy System, a non-invasive TMS medical device cleared by the FDA to treat major depressive disorder, obsessive-compulsive disorder, and anxious depression in adults, as well as adolescent MDD. The company also operates Greenbrook TMS Inc., a wholly owned subsidiary that owns and manages 93 outpatient mental health treatment centers across multiple U.S. states, providing NeuroStar therapy and SPRAVATO® treatments. The business model combines product sales, treatment sessions, and clinical services. Neuronetics maintains a direct sales and customer support organization targeting psychiatrists and other specialists. The company manages its supply chain through third-party manufacturers and is exploring diversification of console manufacturing. It faces competition from other TMS providers and pharmaceutical treatments. The company holds patents covering its NeuroStar systems and potential future products. Neuronetics has a credit facility with $70 million borrowings maturing in 2029 and an accumulated deficit exceeding $450 million. The company’s strategy includes expanding patient access through Greenbrook, piloting new payment models, and leveraging operational efficiencies in treatment centers [S1][S2].

Monte Rosa Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing molecular glue degraders. These are small molecules designed to induce targeted protein degradation, potentially addressing diseases in immunology, inflammation, and oncology. The company is advancing its lead candidate MRT-8102 for chronic inflammatory diseases and is developing its proprietary QuEEN platform to identify additional molecular glue degraders. Monte Rosa collaborates with pharmaceutical partners such as Johnson & Johnson to advance clinical studies. The company is publicly traded on the Nasdaq under the ticker GLUE and is classified as an emerging growth company.

Baidu Inc is a major Chinese technology company specializing in AI and internet services. It operates with a strong foundation in internet content and information services and has expanded into AI-driven platforms and autonomous vehicle technologies. The company maintains compliance with U.S. SEC reporting requirements through annual Form 20-F filings and periodic Form 6-K reports. Baidu's liquidity position as of the end of 2025 shows a current ratio of 1.76 and a cash ratio of 0.33, supported by substantial cash and current assets. Recent corporate governance changes include the resignation of an independent director and adjustments to board committees to maintain governance standards.

Brookfield Infrastructure Corp operates as a global infrastructure company with a diversified portfolio including gas transmission, energy distribution, and logistics services. The company’s revenue streams are primarily derived from regulated and contracted operations across multiple geographies including the United Kingdom, Brazil, Switzerland, France, Singapore, China, Denmark, and the United States. The company’s share capital includes exchangeable shares and class B shares, with voting rights and dividend entitlements structured to reflect economic interests and control. Exchangeable shares can be converted into partnership units or cash equivalents, subject to adjustments for capital events. The company’s board holds redemption rights over exchangeable shares under specified conditions. Financially, the company reported $3.668 billion in revenue and $700 million in net income for the year ended December 31, 2025, with liquidity ratios indicating a current ratio below 1 and a low cash ratio, reflecting the capital-intensive nature of the business.

Brookfield Infrastructure Partners L.P. is a Bermuda exempted limited partnership that serves as the managing general partner of the Holding LP, which owns and operates a diversified portfolio of infrastructure assets globally. The partnership's business includes regulated gas transmission systems in Brazil, regulated distribution operations in the United Kingdom, and global intermodal logistics. The partnership issues units and preferred units representing limited partnership interests, with preferred units having seniority in distributions and liquidation. The partnership's units are listed on the NYSE and TSX, and it maintains a complex capital structure with various classes of units and exchangeable interests. The partnership's financials as of fiscal year 2025 show substantial revenue and net income, with liquidity ratios reflecting current asset and liability balances. Distributions to partners are subject to cash availability and priority rules, with preferred units receiving cumulative fixed or floating quarterly distributions. The partnership's governance and capital structure are governed by detailed agreements filed with the SEC.

BM Acquisition Corp. operates as a special purpose acquisition company (SPAC) incorporated in the Cayman Islands with the primary objective of acquiring or merging with one or more businesses in Southeast Asia. The company targets firms with annual revenues between $15 million and $30 million, aiming to leverage the region's rapid economic growth and favorable demographics. The management team brings extensive financial and operational experience and a strong regional network to source proprietary deals and execute acquisitions. The company holds funds in a U.S.-based trust account to finance its initial business combination and plans to offer target companies an alternative to traditional IPOs by facilitating a faster and potentially more cost-effective path to becoming public. As of the latest filings, BM Acquisition Corp. has not identified any acquisition targets and operates with minimal staff prior to completing a business combination.

Primis Financial Corp. is the bank holding company for Primis Bank, a Virginia state-chartered bank with 24 full-service branches primarily in Virginia and Maryland. The company also operates through online and mobile banking platforms. It owns and leases multiple properties across several states and has a consolidated residential mortgage subsidiary, Primis Mortgage Company (PMC). The company had a significant corporate event in 2025 with the deconsolidation and partial sale of Panacea Financial Holdings (PFH), which had been a consolidated subsidiary. Primis reported a return to profitability in 2025 after losses in prior years, supported by gains from sale-leaseback transactions, investment gains, and mortgage banking income. The company maintains regulatory capital adequacy and liquidity, with no significant legal risks reported. It continues to pay dividends and has an active share repurchase program.

Spirit Aviation Holdings, Inc. is a U.S.-based airline operating a value-focused business model that offers a range of travel options from premium to economical. The company operates a fleet of 131 Airbus A320 family aircraft with high-density seating to maintain low unit costs. It serves over 427 markets across the U.S., Latin America, and the Caribbean. The airline has implemented a transformation plan since 2024 to enhance guest experience and financial results, including new premium travel options and technology modernization. Spirit operates loyalty programs such as the Spirit Saver$ Club and Free Spirit Program to build customer loyalty. The company faces intense competition from major U.S. network and low-cost carriers and is subject to seasonal and economic fluctuations. It sells tickets primarily through direct channels and partners with third-party distributors. Spirit is currently undergoing Chapter 11 bankruptcy restructuring, which impacts its financial condition and operations.

Microvast Holdings, Inc. develops and manufactures advanced lithium-ion battery technologies with a focus on electric commercial vehicles and energy storage systems. Founded in 2006 and headquartered in Texas, the company employs a vertically integrated approach covering core battery materials, cells, modules, packs, thermal management, and battery management systems. Its product portfolio includes multiple cell chemistries such as lithium titanate oxide (LTO), nickel manganese cobalt oxide (NMC), and lithium iron phosphate (LFP), designed for ultra-fast charging, long cycle life, high energy density, and enhanced safety. Microvast serves diverse commercial vehicle markets including buses, trucks, trains, port and mining equipment, and specialty vehicles, with customers across Asia-Pacific, Europe, and North America. Manufacturing capacity is centered in Huzhou, China, with expansion underway, and a module production facility in Germany. The company reported $427.5 million revenue in 2025, with geographic diversification and ongoing investments in R&D and manufacturing expansion. Liquidity and capital resources remain a focus due to substantial debt and capital commitments. The company faces risks related to customer concentration, supply chain, regulatory environment, and capital requirements.

Investors Title Company is a holding company incorporated in North Carolina, operating through subsidiaries including ITIC and NITIC, which underwrite residential and commercial title insurance primarily in the eastern United States and Texas. The company also provides tax-deferred real property exchange services through subsidiaries ITEC and ITAC, and offers management and investment trust services through other subsidiaries. Title insurance policies protect owners and mortgagees against losses from title defects existing prior to policy issuance, with premiums recognized as one-time payments at closing. The business is cyclical and seasonal, influenced by real estate activity, mortgage lending, and economic conditions. The company is subject to extensive state insurance regulation, including licensing, capital and reserve requirements, and periodic examinations. ITIC and NITIC met all statutory requirements as of December 31, 2025. The company also manages reinsurance arrangements to limit risk exposure. Competition is significant in both title insurance and exchange services, with key factors including service quality, price, expertise, and financial strength. The company reported fiscal 2025 revenue of approximately $272.8 million and net income of $35.2 million, with cash and short-term investments totaling about $54.7 million at year-end 2025.

Pangaea Logistics Solutions Ltd. is a provider of seaborne drybulk logistics and transportation services, including terminal and stevedoring services. The company serves a broad industrial customer base requiring transportation of various drybulk cargoes such as grains, coal, iron ore, and other minerals. It operates a fleet of ocean-going vessels across multiple size segments, including Handymax, Supramax, Ultramax, Panamax, and Post-Panamax, with a focus on ice-class vessels for operations in ice-restricted Northern Hemisphere areas. Pangaea derives revenue primarily from contracts of affreightment, voyage charters, and time charters, emphasizing strategic COAs and backhaul cargoes to optimize vessel utilization and profitability. The company manages market risks through short-term chartering, hedging strategies, and a portfolio approach to its fleet. It also provides customized logistics solutions and maintains strong relationships with major industrial customers. The management team has extensive industry experience, and the company operates primarily from offices in the U.S., Denmark, and Singapore.

Agenus Inc. operates as a clinical-stage biotechnology company specializing in immuno-oncology. Its product pipeline includes immune-modulatory antibodies such as botensilimab and balstilimab, a saponin-based vaccine adjuvant platform, and adoptive cell therapies through investments. The company has proprietary discovery platforms and integrated capabilities from target identification to clinical manufacturing. In January 2026, Agenus divested its in-house manufacturing facilities and now relies on third-party contract manufacturing organizations for clinical and commercial supply. Manufacturing processes are complex and not yet validated for commercial scale, with risks of higher costs and supply interruptions. Agenus faces challenges typical of biotech firms including regulatory approvals, market acceptance, pricing and reimbursement pressures, and the need to build or collaborate for commercial capabilities. Financially, as of December 31, 2025, the company held $3.0 million in cash and equivalents, with a current ratio of 0.41, indicating liquidity constraints. The company reported net income for the nine months ended September 30, 2025, following prior losses. Recent news includes Q4 earnings and revenues surpassing estimates in early 2026.

Green Dot Corporation provides prepaid debit card and financial services products, including banking-as-a-service (BaaS) offerings, tax refund processing, and reload networks. The company’s revenue is heavily dependent on a few key partners, notably a single BaaS partner accounting for over 60% of operating revenues and Walmart as a major retail distributor. Its business model relies on the promotion and placement of products by partners and distributors, which are subject to their discretion and competitive pressures. The company experiences seasonal revenue fluctuations, particularly due to tax refund processing services concentrated in the first half of the year. Green Dot operates in a highly competitive and rapidly evolving electronic payments industry, facing competition from larger financial institutions and fintech firms. Technological innovation and fraud risk management are critical operational factors. The company has increased debt obligations and is exploring strategic alternatives, which may affect its business and stock price.

Rallybio Corp is a clinical-stage biotech company focused on developing and commercializing therapies for patients with severe and rare diseases. Its lead product candidate, RLYB116, is a subcutaneously administered, once-weekly inhibitor of complement component 5 (C5), targeting diseases caused by complement dysregulation such as platelet transfusion refractoriness and antiphospholipid syndrome. The company also develops RLYB332, a long-acting antibody targeting matriptase-2 for treatment of iron overload and ineffective erythropoiesis conditions. Rallybio relies on third-party contract manufacturers for clinical and potential commercial supply. The company has entered a merger agreement with Candid, a clinical-stage biotech focused on T-cell engager therapeutics, with a concurrent financing of approximately $505.5 million. Rallybio has reported positive Phase 1 clinical data for RLYB116 and is managing its operations to maximize value from contingent value rights related to pre-merger assets. Financially, Rallybio reported a net loss of $8.98 million and revenue of $858,000 for the fiscal year ended December 31, 2025, with a strong liquidity position supported by cash, short-term investments, and a high current ratio. The company has faced Nasdaq listing compliance challenges and has implemented a reverse stock split to regain compliance.

MetroCity Bankshares, Inc. is a community banking institution with all operations aggregated into one reportable segment. The company primarily generates revenue from interest income and noninterest income related to residential real estate and SBA loans. It manages interest rate risk through an asset liability committee using income simulations and economic value of equity models. The company maintains regulatory capital well above minimum requirements and holds substantial cash and cash equivalents. It also has off-balance sheet commitments including credit extensions and standby letters of credit. The company completed the acquisition of First IC Corporation in December 2025, with integration ongoing. Management assesses internal controls as effective and maintains various borrowing mechanisms to support liquidity and contractual obligations [S1][S2].

PLAYSTUDIOS, Inc. develops free-to-play casual games for mobile and social platforms, including social casino, card, and puzzle games. Its portfolio features titles such as myVEGAS Slots, myVEGAS Blackjack, my KONAMI Slots, POP! Slots, myVEGAS Bingo, MGM Slots Live, and Tetris-branded games. The company operates the playAWARDS loyalty program, which integrates real-world rewards from a global network of hospitality, entertainment, and leisure brands, enhancing player engagement and monetization. Revenue is primarily generated through voluntary in-game purchases of virtual currency and in-game advertising. As of December 31, 2025, the company had 9.9 million average monthly active users and over 100 million game downloads. PLAYSTUDIOS emphasizes live operations, data-driven player management, and performance marketing to optimize player acquisition and retention. The company maintains a founder-led management team with expertise in gaming and loyalty marketing.

Cantor Equity Partners III, Inc. operates as a special purpose acquisition company (SPAC) incorporated in the Cayman Islands in 2020. Its primary objective is to identify and complete a Business Combination with a target company, focusing on sectors such as financial services, digital assets, healthcare, real estate services, technology, and software. The company is affiliated with Cantor, a diversified financial and real estate services firm, leveraging its management team's expertise and network to source and execute acquisitions. The company completed its IPO in June 2025, raising $276 million, which is held in a Trust Account pending the Business Combination. It has a 24-month window from the IPO to complete the Business Combination or else liquidate and redeem public shares. The company has entered into a Business Combination Agreement with AIR and related entities, which will result in a new publicly traded entity, Pubco. The company currently has minimal operating infrastructure, with two executive officers and no employees, and relies on its management and affiliates for operations until the Business Combination is completed.